These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8750190)

  • 21. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
    Gotley DC; Fawcett J; Walsh MD; Reeder JA; Simmons DL; Antalis TM
    Br J Cancer; 1996 Aug; 74(3):342-51. PubMed ID: 8695347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.
    Salles G; Zain M; Jiang WM; Boussiotis VA; Shipp MA
    Blood; 1993 Dec; 82(12):3539-47. PubMed ID: 7505117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A PCR-based method for the analysis of human CD44 splice products.
    van Weering DH; Baas PD; Bos JL
    PCR Methods Appl; 1993 Oct; 3(2):100-6. PubMed ID: 7505677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
    Screaton GR; Bell MV; Jackson DG; Cornelis FB; Gerth U; Bell JI
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12160-4. PubMed ID: 1465456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice.
    Hirano H; Screaton GR; Bell MV; Jackson DG; Bell JI; Hodes RJ
    Int Immunol; 1994 Jan; 6(1):49-59. PubMed ID: 7511928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear hyaluronidase 2 drives alternative splicing of
    Midgley AC; Oltean S; Hascall V; Woods EL; Steadman R; Phillips AO; Meran S
    Sci Signal; 2017 Nov; 10(506):. PubMed ID: 29162741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
    Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapeutic approaches to primary and metastatic brain tumors: II. ribozyme-mediated suppression of CD44 expression.
    Ge L; Resnick NM; Ernst LK; Salvucci LA; Asman DC; Cooper DL
    J Neurooncol; 1995 Dec; 26(3):251-7. PubMed ID: 8750191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro selection of exonic splicing enhancer sequences: identification of novel CD44 enhancers.
    Woerfel G; Bindereif A
    Nucleic Acids Res; 2001 Aug; 29(15):3204-11. PubMed ID: 11470878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.
    Nagasaka S; Tanabe KK; Bruner JM; Saya H; Sawaya RE; Morrison RS
    J Neurosurg; 1995 May; 82(5):858-63. PubMed ID: 7536236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
    Stauder R; Eisterer W; Thaler J; Günthert U
    Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma.
    Stauder R; Van Driel M; Schwärzler C; Thaler J; Lokhorst HM; Kreuser ED; Bloem AC; Günthert U; Eisterer W
    Blood; 1996 Oct; 88(8):3101-8. PubMed ID: 8874209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
    Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
    Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of variant CD44 epitopes in human astrocytic brain tumors.
    Eibl RH; Pietsch T; Moll J; Skroch-Angel P; Heider KH; von Ammon K; Wiestler OD; Ponta H; Kleihues P; Herrlich P
    J Neurooncol; 1995 Dec; 26(3):165-70. PubMed ID: 8750182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation stabilizes alternatively spliced CD44 mRNA transcripts in breast cancer cells: inhibition by antisense complementary to casein kinase II mRNA.
    Formby B; Stern R
    Mol Cell Biochem; 1998 Oct; 187(1-2):23-31. PubMed ID: 9788739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variant CD44 expression by human fibroblasts.
    Rajarajan A; Bloor BK; Desai H; Stokes A; Odell EW
    Biomarkers; 2008 May; 13(3):307-18. PubMed ID: 18415803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of CD44RC, a novel alternatively spliced soluble CD44 isoform that can potentiate the hyaluronan binding activity of cell surface CD44.
    Chiu RK; Carpenito C; Dougherty ST; Hayes GM; Dougherty GJ
    Neoplasia; 1999 Nov; 1(5):446-52. PubMed ID: 10933060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schwann cell tumors express characteristic patterns of CD44 splice variants.
    Sherman L; Skroch-Angel P; Moll J; Schwechheimer K; Ponta H; Herrlich P; Hofmann M
    J Neurooncol; 1995 Dec; 26(3):171-84. PubMed ID: 8750183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative splicing as a novel of means of regulating the expression of therapeutic genes.
    Hayes GM; Carpenito C; Davis PD; Dougherty ST; Dirks JF; Dougherty GJ
    Cancer Gene Ther; 2002 Feb; 9(2):133-41. PubMed ID: 11857030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.